First Real-World Experience With Bigfoot Unity: A 6-Month Retrospective Analysis.
| Autor: | Baliga BS; East Alabama Endocrinology PC, Opelika, AL., Tillman JB; Bigfoot Biomedical, Inc., Milpitas, CA., Olson B; Bigfoot Biomedical, Inc., Milpitas, CA., Vaughan S; Bigfoot Biomedical, Inc., Milpitas, CA., Sheikh FN; Bigfoot Biomedical, Inc., Milpitas, CA., Malone JK; Bigfoot Biomedical, Inc., Milpitas, CA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Clinical diabetes : a publication of the American Diabetes Association [Clin Diabetes] 2023 Fall; Vol. 41 (4), pp. 539-548. Date of Electronic Publication: 2023 Jun 21. |
| DOI: | 10.2337/cd22-0126 |
| Abstrakt: | The Bigfoot Unity Diabetes Management System, a smart pen cap system cleared by the U.S. Food and Drug Administration in May 2021, incorporates continuous glucose monitoring data, real-time glycemic alerts, and clinician-directed dose recommendations. This study analyzed real-world clinical outcomes data for an initial cohort ( n = 58, from 13 clinics) managing multiple daily injection insulin therapy using the pen cap system for 6 months. We examined glycemic control, including hypoglycemia events and interaction with and use of the pen cap system. In a cohort mainly consisting of adults with type 2 diabetes and an average age of 62 years, the results demonstrate close adherence to established glycemic targets, including a relatively short amount of time spent in the hypoglycemic range. Competing Interests: B.S.B. has received consulting fees and is on a paid speakers bureau for Bigfoot Biomedical, Inc. J.B.T., B.O., S.V., and J.K.M. are employees of Bigfoot Biomedical, Inc. F.N.S. is a former employee of Bigfoot Biomedical, Inc. (© 2023 by the American Diabetes Association.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|